NASDAQ:DH

Definitive Healthcare (DH) Stock Price, News & Analysis

$5.32
+0.15 (+2.90%)
(As of 05/10/2024 ET)
Today's Range
$4.93
$5.37
50-Day Range
$5.17
$8.92
52-Week Range
$4.38
$12.45
Volume
2.91 million shs
Average Volume
525,581 shs
Market Capitalization
$626.64 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$9.94

Definitive Healthcare MarketRank™ Stock Analysis

Analyst Rating
Hold
2.10 Rating Score
Upside/​Downside
86.9% Upside
$9.94 Price Target
Short Interest
Healthy
5.10% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
-0.03mentions of Definitive Healthcare in the last 14 days
Based on 32 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
27.27%
From $0.11 to $0.14 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.91 out of 5 stars

Medical Sector

196th out of 921 stocks

Prepackaged Software Industry

58th out of 202 stocks

DH stock logo

About Definitive Healthcare Stock (NASDAQ:DH)

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution. The company's platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate firms, financial institutions, and other organizations in the healthcare ecosystem. The company was founded in 2011 and is headquartered in Framingham, Massachusetts.

DH Stock Price History

DH Stock News Headlines

Did You Get Your Free Bitcoin Yet?
And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.
Did You Get Your Free Bitcoin Yet?
And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.
Q1 2024 Definitive Healthcare Corp Earnings Call
Definitive Healthcare Corp Class A
DH Apr 2024 5.000 put
DH Jul 2024 5.000 put
See More Headlines
Receive DH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Definitive Healthcare and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/28/2024
Today
5/11/2024
Next Earnings (Estimated)
8/12/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Prepackaged software
Sub-Industry
N/A
Fax
N/A
Employees
950
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$9.94
High Stock Price Target
$15.00
Low Stock Price Target
$7.00
Potential Upside/Downside
+86.9%
Consensus Rating
Hold
Rating Score (0-4)
2.10
Research Coverage
10 Analysts

Profitability

Net Income
$-202,390,000.00
Pretax Margin
-122.58%

Debt

Sales & Book Value

Annual Sales
$251.41 million
Cash Flow
$2.24 per share
Book Value
$10.31 per share

Miscellaneous

Free Float
100,309,000
Market Cap
$626.64 million
Optionable
Not Optionable
Beta
1.41
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

  • Mr. Jason Ronald Krantz (Age 50)
    Founder, Executive Chairman & Interim CEO
    Comp: $130.38k
  • Mr. Jonathan Maack (Age 45)
    President
    Comp: $687.21k
  • Mr. Richard Douglas BoothMr. Richard Douglas Booth (Age 55)
    Chief Financial Officer
    Comp: $579.47k
  • Ms. Kate Marie Shamsuddin Jensen (Age 37)
    Chief Product Officer
    Comp: $431.86k
  • Ms. Carrie Lazorchak (Age 54)
    Chief Revenue Officer
    Comp: $110.49k
  • Mr. Scott Oberlink
    Chief Technology Officer
  • Mr. Matthew Ruderman
    Chief Legal Officer & Secretary
  • Mr. Craig Hazenfield
    Chief People Officer
  • Mr. Ram Sharma
    Executive Vice President of Life Sciences

DH Stock Analysis - Frequently Asked Questions

Should I buy or sell Definitive Healthcare stock right now?

10 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Definitive Healthcare in the last twelve months. There are currently 9 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" DH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in DH, but not buy additional shares or sell existing shares.
View DH analyst ratings
or view top-rated stocks.

What is Definitive Healthcare's stock price target for 2024?

10 Wall Street research analysts have issued twelve-month price objectives for Definitive Healthcare's shares. Their DH share price targets range from $7.00 to $15.00. On average, they predict the company's share price to reach $9.94 in the next year. This suggests a possible upside of 86.9% from the stock's current price.
View analysts price targets for DH
or view top-rated stocks among Wall Street analysts.

How have DH shares performed in 2024?

Definitive Healthcare's stock was trading at $9.94 at the start of the year. Since then, DH shares have decreased by 46.5% and is now trading at $5.32.
View the best growth stocks for 2024 here
.

When is Definitive Healthcare's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, August 12th 2024.
View our DH earnings forecast
.

How were Definitive Healthcare's earnings last quarter?

Definitive Healthcare Corp. (NASDAQ:DH) issued its earnings results on Wednesday, February, 28th. The company reported ($0.01) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.01 by $0.02. The firm had revenue of $65.93 million for the quarter, compared to analysts' expectations of $66.01 million. Definitive Healthcare had a negative net margin of 80.40% and a positive trailing twelve-month return on equity of 0.43%.

What ETFs hold Definitive Healthcare's stock?

ETFs with the largest weight of Definitive Healthcare (NASDAQ:DH) stock in their portfolio include Fidelity Digital Health ETF (FDHT) and Global X Telemedicine & Digital Health ETF (EDOC).First Trust Nasdaq Lux Digital Health Solutions ETF (EKG).

What guidance has Definitive Healthcare issued on next quarter's earnings?

Definitive Healthcare issued an update on its second quarter 2024 earnings guidance on Wednesday, May, 8th. The company provided EPS guidance of 0.080-0.090 for the period, compared to the consensus estimate of 0.090. The company issued revenue guidance of $62.0 million-$63.5 million, compared to the consensus revenue estimate of $65.2 million.

When did Definitive Healthcare IPO?

Definitive Healthcare (DH) raised $350 million in an initial public offering (IPO) on Wednesday, September 15th 2021. The company issued 15,555,555 shares at $21.00-$24.00 per share.

Who are Definitive Healthcare's major shareholders?

Definitive Healthcare's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Conestoga Capital Advisors LLC (4.75%), Vanguard Group Inc. (3.85%), Riverbridge Partners LLC (1.49%), Raymond James & Associates (0.72%), Swiss National Bank (0.09%) and Mirae Asset Global Investments Co. Ltd. (0.06%). Insiders that own company stock include David Randall Winn, Jeffrey Charles Haywood, Richard Douglas Booth and Sea Vii Management, Llc.
View institutional ownership trends
.

How do I buy shares of Definitive Healthcare?

Shares of DH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:DH) was last updated on 5/11/2024 by MarketBeat.com Staff

From Our Partners